US 9731011
Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
granted A61KA61K31/704A61K35/74
Quick answer
US patent 9731011 (Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/704, A61K35/74, A61K38/217, A61K39/3955